Neurizon Therapeutics Limited, a clinical-stage biotech company dedicated to advancing innovative treatments for ...

After winning approval in the United States back in September, Sanofi Genzyme’s multiple sclerosis drug, aubagio, has won approval for use in Australia. The Australian Therapeutic Goods ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

The drug is a recombinant version of the enzyme ... of glycogen to toxic levels that damage muscle cells. Sanofi's Genzyme rare diseases division already sells another enzyme replacement therapy ...

Genzyme Approved by US FDA Stem cell mobilizer Use in combination with G-CSF AMD070 Genzyme Suspended (Phase I/II) HIV A derivative of AMD3100 that can be orally administered. Liver histology ...

An E. coli outbreak last year linked to romaine lettuce killed one person and sickened dozens of others, but the Food and Drug Administration never told the public about it. According to an FDA ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. WASHINGTON — The Food and Drug Administration will remove industry representatives from ...

The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with ...

April 18 (Reuters) - The U.S. Food and Drug Administration approved the use of Sanofi (SASY.PA), opens new tab and Regeneron's (REGN.O), opens new tab blockbuster drug Dupixent for patients with a ...

April 14 (UPI) --The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to treat Type 2 diabetes, have been found in the United States.